B.Braun Accelerator Call for Innovative Solutions & Products

B. Braun is one of the world's leading providers and manufacturers of healthcare solutions today. The company employs more than 60,000 employees in 64 countries and is looking for European early-stage startups with working-prototypes in the HealthTech and MedTech sector for their upcoming accelerator program.

B. Braun is looking for innovative solutions & products in the area of ambulatory & home care taking into account the total patient pathway.

Innovation Topics

  • Data Management and Communication
    Including but not limited to: Patient Discharge Management, Recovery Process, Matchmaking Software, Supply Chain Mgmt, Education & Technology, HR Tools
  • Digital Health and Home Care
    Including but not limited to: Patient Discharge Management, Patient Empowerment, Preventive Medicine, Tele-Monitoring, Tele Medicine, Follow-up Care
  • Disruptive Solutions in the Medtech and Healthtech Field
    Industry revolutionary - out of the box - solutions

Technologies

Smart Devices, Wearables, Sensorics, IoT, Blockchain, Big Data Analytics & Artificial Intelligence, Machine Learning, Deep Learning, Medical Robotics, Virtual & Augmented Reality, Genomics

Therapy Fields

Examples: Dialysis, Diabetes, Stoma, Wound Care, Incontinence, Nutrition, Infusion Therapy

What are the benefits?

6 months acceleration program, jump-start pilot funding up to € 20K, non equity program, individual mentoring & consulting, network of experts, co-working space, post acceleration & implementation support

Pitching session for selecting the top startups: 19 December 2017

For further information and to apply, please visit:
https://www.f6s.com/bbraun-accelerator/about

Most Popular Now

Brain-Computer Interface Enables People …

Tablets and other mobile computing devices are part of everyday life, but using them can be difficult for people with paralysis. New research from the BrainGate consortium shows that a...

AI System may Accelerate Search for Canc…

Searching through the mountains of published cancer research could be made easier for scientists, thanks to a new AI system. The system, called LION LBD and developed by computer scientists...

AI-Pathway Companion from Siemens Health…

At the Congress of the Radiological Society of North America (RSNA 2018) in Chicago, USA, Siemens Healthineers is presenting AI-Pathway Companion* for the first time. It is a clinical decision...

Philips Latest 'Future Health Index' Rep…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced publication of the latest Future Health Index (FHI) report. 'Telehealth: delivering value across institutional and geographical borders...

NHS Pioneers Win with InterSystems at HT…

Two pioneering NHS organisations have been recognised at the 2018 HTN Awards for their innovative work using InterSystems technology to help transform care for patients. The judges, who included GPs...

New China and US Studies Back Use of Pul…

Fast and easy blood pressure monitoring could soon be at your fingertips - literally - thanks to new University of British Columbia research that showed blood pressure (BP) can be...

AOK Counts on the Orchestra eHealth Suit…

The AOK community builds a digital health network for its insurants and thus takes on a pioneering task among German health insurances. Through the digital health network its 25 million...

Australian Health Region Boosts Patient …

Patients and clinicians will benefit from easy access to critical real-time patient information at the bedside after Australian population health services provider ACT Health signed a further contract with Patientrack's...

Syntropy to Unlock the Value of Scientif…

Merck, a leading science and technology company, and software company Palantir Technologies, today announced their intent to form a joint venture under the brand name Syntropy. Syntropy is expected to...

FDA Grants Breakthrough Device Designati…

Bayer announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Artificial Intelligence Software for Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Pattern Recognition, which Bayer is...

DIATOMIC Launches its Final Call to Dist…

In its second and final open call for application experiments, DIATOMIC is offering a total of €1.610.000 equity-free funding plus acceleration services to the best startups/ SMEs and Competence Centers...